SK74496A3 - Organoleptically acceptable oral pharmaceutical compositions - Google Patents

Organoleptically acceptable oral pharmaceutical compositions Download PDF

Info

Publication number
SK74496A3
SK74496A3 SK744-96A SK74496A SK74496A3 SK 74496 A3 SK74496 A3 SK 74496A3 SK 74496 A SK74496 A SK 74496A SK 74496 A3 SK74496 A3 SK 74496A3
Authority
SK
Slovakia
Prior art keywords
acid
ibuprofen
organoleptically acceptable
eutomer
oral pharmaceutical
Prior art date
Application number
SK744-96A
Other languages
English (en)
Slovak (sk)
Inventor
Leslie G Humber
Gerald L Reuter
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SK74496A3 publication Critical patent/SK74496A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK744-96A 1995-06-13 1996-06-10 Organoleptically acceptable oral pharmaceutical compositions SK74496A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16995P 1995-06-13 1995-06-13
CN96112209A CN1155417A (zh) 1995-06-13 1996-06-12 S(+)-布洛芬的口服制剂

Publications (1)

Publication Number Publication Date
SK74496A3 true SK74496A3 (en) 1997-04-09

Family

ID=37709653

Family Applications (1)

Application Number Title Priority Date Filing Date
SK744-96A SK74496A3 (en) 1995-06-13 1996-06-10 Organoleptically acceptable oral pharmaceutical compositions

Country Status (22)

Country Link
US (1) US5780046A (ru)
EP (1) EP0753296A3 (ru)
JP (1) JPH092949A (ru)
CN (1) CN1155417A (ru)
AR (1) AR002442A1 (ru)
AU (1) AU715367B2 (ru)
BR (1) BR9602759A (ru)
CA (1) CA2178691A1 (ru)
CZ (1) CZ170396A3 (ru)
EA (1) EA000046B1 (ru)
EE (1) EE9600068A (ru)
HU (1) HUP9601619A3 (ru)
IL (1) IL118637A (ru)
IN (1) IN182039B (ru)
MA (1) MA23908A1 (ru)
NO (1) NO962490L (ru)
NZ (1) NZ286790A (ru)
PL (1) PL314731A1 (ru)
SK (1) SK74496A3 (ru)
TR (1) TR199600498A2 (ru)
TW (1) TW442287B (ru)
ZA (1) ZA964929B (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
EP0974366B1 (en) 1997-03-28 2006-10-18 Eisai Co., Ltd. Oral pharmaceutical preparations decreased in bitterness by masking
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
US6482465B1 (en) 1997-06-24 2002-11-19 Biovail Technologies Ltd. Positive hydration method of preparing confectionery and product therefrom
CA2295238A1 (en) * 1997-06-24 1998-12-30 S. Rao Cherukuri Positive hydration method of preparing confectionery and product therefrom
US6673380B2 (en) 1998-11-17 2004-01-06 Mcneil-Ppc, Inc. Fortified confectionery delivery systems and methods of preparation thereof
AU2006202991B2 (en) * 1998-01-02 2009-01-08 Mcneil-Ppc, Inc. Ibuprofen composition
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
WO2001064190A1 (fr) * 2000-03-01 2001-09-07 Eisai Co., Ltd. Comprimes se desagregeant rapidement contenant du poly(alcool de vinyle)
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
PE20020102A1 (es) * 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
BRPI0116865B8 (pt) * 2001-01-23 2021-05-25 Gador Sa composição compreendendo bisfosfonatos para prevenção e/ou tratamento de doenças metabólicas dos ossos, processo para preparar tal composição e uso desta
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
GB0113843D0 (en) 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US6866862B2 (en) * 2001-10-05 2005-03-15 Rubicon Scientific Animal feeds including heartworm-prevention drugs
US7052712B2 (en) * 2001-10-05 2006-05-30 Rubicon Scientific Llc Animal feeds including actives and methods of preparing same
US6716448B2 (en) 2001-10-05 2004-04-06 Rubicon Scientific Llc Domesticated household pet food including maintenance amounts of ivermectin
US6551615B1 (en) 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
IL153124A (en) * 2002-11-27 2010-06-30 Herbal Synthesis Corp Solid composition that can be glued to the lining
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
US20080255104A1 (en) * 2004-05-04 2008-10-16 Equitech Corporation Nsaid Compositions
JP2012046540A (ja) * 2004-05-07 2012-03-08 Daiichi Sankyo Healthcare Co Ltd イブプロフェン含有医薬組成物
EP1796635A2 (en) * 2004-09-14 2007-06-20 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
US20070232638A1 (en) * 2006-04-03 2007-10-04 Howard Brooks-Korn Opiopathies
CN101077343B (zh) * 2006-12-12 2010-06-30 蚌埠丰原涂山制药有限公司 右旋布洛芬颗粒及制备方法
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
US8445545B2 (en) * 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
AU2010262738A1 (en) * 2009-05-20 2011-10-13 Lingual Consegna Pty Ltd Buccal and/or sublingual therapeutic formulation
US9636284B2 (en) 2010-03-31 2017-05-02 Johnson & Johnson Consumer Inc. Oral care compositions
CN102258490B (zh) * 2011-07-01 2012-10-03 中美天津史克制药有限公司 布洛芬咀嚼片
FR2991582B1 (fr) * 2012-06-11 2014-06-13 Isp Investments Inc Extrait de fibres de coton et composition cosmetique et leur utilisation pour proteger, nourrir et hydrater la peau
RU2015114433A (ru) 2012-09-18 2016-11-10 МакНЕЙЛ-ППС, ИНК. Пероральные дозированные формы с замедленным высвобождением, содержащие частицы легкоплавкого производного пропионовой кислоты
CN104640537A (zh) 2012-09-18 2015-05-20 麦克内尔-Ppc股份有限公司 用于口服剂型的低熔点丙酸衍生物粒子
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4873231A (en) * 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
ES2055685T3 (es) * 1986-11-14 1994-09-01 Puetter Medice Chem Pharm Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5100918A (en) * 1989-05-25 1992-03-31 Sterling Drug, Inc. Prevention or treatment of sunburn using the S(+) isomer of ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
HUT59653A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alcanoic acids and alpha-hydroxy-alcanoic acids and pharmaceutical compositions containing them as active components
CA2102530C (en) * 1991-05-13 2003-07-29 Bernard J. Armitage Therapeutic agent
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
HUP9601619A3 (en) 1999-05-28
EP0753296A2 (en) 1997-01-15
CZ170396A3 (en) 1997-04-16
NZ286790A (en) 1998-02-26
HUP9601619A2 (en) 1997-02-28
US5780046A (en) 1998-07-14
EE9600068A (et) 1996-12-16
EP0753296A3 (en) 1997-04-23
EA199600028A3 (ru) 1997-03-31
IN182039B (ru) 1998-12-12
AR002442A1 (es) 1998-03-11
HU9601619D0 (en) 1996-08-28
NO962490D0 (no) 1996-06-12
ZA964929B (en) 1997-12-10
TR199600498A2 (tr) 1997-03-21
CN1155417A (zh) 1997-07-30
EA000046B1 (ru) 1998-04-30
CA2178691A1 (en) 1996-12-14
TW442287B (en) 2001-06-23
AU715367B2 (en) 2000-02-03
EA199600028A2 (ru) 1996-12-30
JPH092949A (ja) 1997-01-07
IL118637A0 (en) 1996-10-16
NO962490L (no) 1996-12-16
BR9602759A (pt) 1998-04-22
PL314731A1 (en) 1996-12-23
MA23908A1 (fr) 1996-12-31
IL118637A (en) 1999-10-28
AU5588196A (en) 1997-01-02

Similar Documents

Publication Publication Date Title
SK74496A3 (en) Organoleptically acceptable oral pharmaceutical compositions
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6027746A (en) Chewable soft gelatin-encapsulated pharmaceutical adsorbates
US5958445A (en) Oral Formulations of S(+)-etodolac
ES2220000T3 (es) Composicion de ibuprofeno.
US9827197B2 (en) Diclofenac formulations and methods of use
US20080020065A1 (en) Rapid-melt compositions, methods of making same and method of using same
US20100010101A1 (en) Rapid-Melt Compositions and Methods of Making Same
Dahiya et al. Chewable tablets: a comprehensive review
JPH1149666A (ja) 直接的に圧縮可能な顆粒
PL175988B1 (pl) Pastylka nikotynowa
Gadhavi et al. Medicated Chewing Gum-A 21st Century Drug Delivery Sysytem
JPH09501421A (ja) 薬物／β−シクロデキストリン複合物を酸−塩基カップルと組み合わせて含有する医薬組成物
KR20070049962A (ko) 경구 고형 제제 및 그의 제조 방법
Jadhav et al. A comprehensive review on: medicated chewing gum
KR20060134144A (ko) 나테글리니드 함유 제제
US6793935B2 (en) Mineral supplement
JPH1135486A (ja) 薬用固形製剤
JP4634589B2 (ja) 食品又は医薬品易服用化剤
WO1995020954A1 (en) Tablets containing thyroid hormones
MXPA99001598A (en) Inhibiting undesirable taste in oral compositions